Investors could be overestimating the contribution of Hims & Hers' compounded GLP-1 medications to its top line. Read why I ...

With federal support, universities produce world-changing discoveries and the next generation of exquisitely well-trained ...

Cash, weapons and a shatter lab were among items found in properties in Newcastle that have been issued with closure notices ...

Compugen's innovative approach targets under-explored immune pathways like PVRIG and IL-18 binding protein. Read why I'm ...

Two Massachusetts men were arrested after bringing a massive drug operation over state lines, investigators say.

A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

The School of Medicine is a major international centre for teaching and research, and committed to the pursuit of improved human health. We combine progressive healthcare education and patient care ...

The Partnership for Safe Medicines, a pharmaceutical industry group, is asking the U.S. FDA to “take action” against a “dangerous” ad that Hims ...

“We are very excited to bring this offering to oncologists in partnership with Foundation Medicine, and we look forward to a strong collaboration with a mutual goal of advancing patient care.

In order to remedy the drug safety crisis without significantly reducing access to vital medicines ... and financial support from UN agencies, the Partnership for Africa's Development (NEPAD ...

In a Feb. 5 letter to the agency, Shabbir Imber Safdar, executive director of the Partnership for Safe Medicines (PSM), called the ad “blatantly misleading,” noting its written warning doesn ...